Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-ass...
Leadership
William P. Quinn
CEO, CFO, President, Secretary & Director
Grant Yonehiro C.F.A., M.B.A.
COO & Chief Business Officer
Sarah Nemec
Senior VP of Finance & Principal Accounting Officer
